Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:26 Apr 2017 03:08:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1413.40 [ -1.35% ]TCS 2310.00 [ -0.06% ]

Sensex30134.32
191.08 0.64%

Nifty9347.60
41.00 0.44%

Midcap14759.39
-21.19 -0.14%

Smallcap15285.79
-94.10 -0.61%


Bse Corporate Announcements Back
Pharma Announces Positive Results of Two Pivotal Phase-3 Clinical Trials of Tildrakizumab
Sun Pharma announced that two pivotal Phase-3 clinical trials evaluating the efficacy and safety of the investigational IL-23p19 inhibitor antibody tildrakizumab (MK-3222) in patients with moderate-to-severe plaque psoriasis met their primary endpoints for both evaluated doses.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com